Abstract. Bcl-2 is a mitochondrial-and perinuclearassociated protein that prolongs the lifespan of a variety of cell types by interfering with programmed cell death (apoptosis). Bcl-2 seems to function in an antioxidant pathway, and it is believed that membrane attachment mediated by a COOH-terminal hydrophobic tail is required for its full activity. To identify critical regions in bcl-2c~ for subcellular localization, activity, and/or interaction with other proteins, we created, by site-directed mutagenesis, various deletion, truncation, and point mutations. We show here that membrane attachment is not required for the survival activity of bcl-2ot. A truncation mutant of bcl-2ot lacking the last 33 amino acids (T3.1) including the hydrophobic COOH terminus shows full activity in blocking apoptosis of nerve growth factor-deprived sympathetic neurons or TNF-o~-treated L929 fibroblasts. Confocal microscopy reveals that the T3 mutant departs into the extremities of neurites in neurons and filopodias in fibroblasts. Consistently, T3 is predominantly detected in the soluble fraction by Western blotting, and is not inserted into microsomes after in vitro transcription/translation. We further provide evidence for motifs (S-N and S-I/) at the NH2 and COOH terminus of bcl-2, which are crucial for its activity.
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I
N both vertebrates and invertebrates, cell numbers are controlled by a balance between cell renewal and cell death. Any disruption of this balance may result in neoplasia. Whereas cell proliferation and its aberrances have been extensively studied, relatively little is known about the regulation of cell death (20, 51) . Cell death can occur by two distinct mechanisms, apoptosis or necrosis. In the former case, the cell actively participates in its own demise, characterized by plasma membrane blebbing, cell volume loss, nuclear condensation, and endonucleolytic degradation of DNA into nucleosomal intervals (DNA ladder) (67) . It is now clear that apoptosis occurs under a wide range of primarily physiological processes, including the removal of interdigital cells during embryonic digit formation (32) , the elimination of massive numbers of neurons generated in early developments to ensure refinement of connections at later stages (52) , the deletion of autoreactive T and B cell clones during maturation (54) , the formation of diverse immune cells from progenitor cells (54) , the involution or self renewal of epithelial tissues/glands (28) , and in tumor regression (66) . In all these cases, the purpose of apoptosis is to actively remove superfluous cells, cells with inappropriate specificity or developmental capacity, or cells that have already served their purpose (20, 52, 54) . This removal of cells is achieved by changing the levels of hormones and growth factors in the cellular environment.
Although many of the extracellular signals that regulate apoptosis in different cell types have been identified, the biochemical mechanisms and identities of the gene products responsible for this process are only now being elucidated (16, 20, 24, 51) . Genetic analysis of the nematode Caenorhabditis elegans has led to the identification of several genes that affect various steps in programmed cell death occurring during development. The ted-3 and ced-4 genes are thought to be necessary for apoptosis to occur because mutations that inactivate either of these result in the survival of cells that would otherwise die (19) . In contrast, the ced-9 gene appears to function in preventing apoptosis because a gain-offunction mutation of this gene eliminates apoptosis (30) .
This implies that both effector and repressor genes will also exist in mammalian cell death pathways. One such mammalian gene has been identified as bel-2. Bcl-2 has been isolated from follicular B cell lymphomas where it is overexpressed as a result of a t(14;18) chromosomal translocation (4, 14, 62) . It represents a novel oncoprotein that appears to predispose cells for carcinogenesis by enhancing their lifespan rather than their proliferation (36, 41) . Gene transfer studies have indicated that bcl-2 blocks cell death induced by a variety of stimuli. It confers survival to certain hematopoieric cell lines after growth factor withdrawal (35, 49, 63) , protects primary neuronal cell cultures (1, 26) as well as PC12 (5) from degradation induced by nerve growth factor depletion, spares cells from death induced by irradiation (53, 56) , heat shock, ethanol, methotrexate, glucose and serum withdrawal, membrane peroxidation, free-radical induced damage (34, 39, 61, 68) , TNF (31) , and glucocorticoid (2, 53, 56) , extends the survival of virally infected cells to allow viral persistance (3, 44) and renders tumor cells markedly resistant to killing by a wide variety of antineoplastic drugs (46, 64) . Redirection of bel-2 expression to cortical thymocytes in transgenic mice led to cells that were now resistant to glucocorticoid-, T-irradiation-, and anti-T cell receptor-induced cell death (53, 56) .
Recent results point to an important role of bcl-2 in an antioxidant pathway (34, 39) . How bel-2 exerts this function is, however, still poorly defined. A major hint could provide four recently identified proteins that interact with bcl-2 (bcl-xs, bcl-xL, bax, and R-ras) (7, 22, 50) . Two of them, bcl-xs and bax, are bcl-2 homologues that can negatively regulate the survival activity of bel-2 in a dominant fashion (7, 50) . Since bax can form heterodimers with bcl-2 in vivo, it is believed that the death-inducing effect of the former is either caused by sequestering the latter or by directing the heterodimer to effectors of apoptosis instead of cell survival (50) . It is, therefore, important to define the regions in bcl-2 that interact with bax/bcl-xs or downstream effectors.
Another unresolved issue is the intracellular site of action ofbel-2. In some cells, confocal microscopy and subcellular fractionation studies revealed an association ofbcl-2 with the mitochondrial membrane (35) . A recent study by Nguyen et al. (48) indicates that the COOH-terminal, hydrophobic 22 amino acids of bcl-2 serves as a signal/anchor segment to target bcl-2 to the outer mitochondrial membrane. In other ceils, bcl-2 has mainly been locali7ed to the endoplasmic reticulum and the nuclear membrane (3, 12, 38, 45a) . Consistent with the latter observation, bcl-2 was still able to prevent the death of cells that lacked mitochondria DNA and, thus, an intact respiratory chain (38) . These findings indicated that the action of bcl-2 may not be limited to one particular subcellular region but might occur at numerous sites, depending on the cell examined.
The bcl-2 gene can encode for two proteins, bel-2o~ and bcl-2/3, which differ only in their carboxyl tails because of an alternative splicing mechanism (60) . Whereas overexpressed bcl-2/3 predominantly resides in the cytoplasm and lacks survival activity, bel-2o~ is membrane bound and capable of conferring cell survival (58) . This difference has been attributed to the presence of a hydrophobic domain in the carboxyl terminus of bcl-2ct (13) , which is thought to act as a transmembrane anchor. Removal of this stretch has previously been shown to mitigate the survival activity of bcl-2oL (3). A recent report by Hockenbery et al. (34) , however, suggested that a soluble bcl-2 lacking this stretch may still exert partial survival activity.
In an attempt to define bcl-2 functional motifs, regions required for subcellular localization and/or sites of interaction with other proteins, we generated bel-2 mutants by sitedirected mutagenesis and examined them for activity and subcellnlar distribution by microinjection into the nuclei of nerve growth factor (NGF)l-deprived neurons (26) .
Materials and Methods

Cell Culture
Sympathetic neurons from superior cervical ¢,Rnslia of newborn rats were cultured as previously described (29) . L929 murine fibrobiasts and their derivatives were maintained in RPMI medium supplemented with 10% fetal calf serum (Gibco Laboratories, Grand Island, NY).
Antibodies
A polyclonal antiserum _against a 14-amino acid peptide encompassing domain 2 of murine bcl-2 (GAAFFPGIFSFQPE) was generated in rabbits. The peptide was synthesized by the TASP method (23) . For Western immunoblotting, the bcl-2 antiserum dilution was 1:2,000, for immunocytochemistry 1:200. Part of the antibody was affinity purified on nitrocellulose strips containing a GST-bcl-2 fusion protein as described before (21) . The monospecific 27-4 antibody obtained was used at dilutions 1:500 for Western blots and 1:100 for immqnocytochemistry. Secondary antibodies were an alkaline phosphatase-conjugated goat anti-rabbit whole antibody for Western blots (Sitrma Immunc~hemicals, St. Louis, MO) and a FITCconjugated goat anti-rabbit IgG (Jackson ImmunoResearch Labs., Inc., West Grove, PA).
cDNA Cloning and Construction of Expression Vectors
The routine bol-2 eDNA was obtained by PCR amplification of a routine B~I T cell library using the primers GOTAC~rtt:rrrlt:OGGG and CGC~TTrGTCGACCTCACTTGTG. Whereas a PstI site was introduced into the 3' primer, the 5' primer already contained a Pstl site upstream of the ATG start codon. The amplified cDNA was cloned into the PstI site of pSK + Blueseript (Stratagane, La Jolla, CA), and the correct sequence confirmed by sequencing. Subsequently, the bel-2 cDNA was cloned into the HiednI site of the retroviral vector, pMVI2 for eukaryotic ~pres-sion (kindly provided by I. B. Weinstein and R. S. Kranss, ColumbiaPresbyterian Cancer Center, Columbia University, College of Physicians and Surgeons, New York). lkl-2/psK + was cut with Hindm and Sma and ligeted at the 5' end into the HindIII site of pMV12. For site-directed mutagenesis, the bci-2 eDNA was cloned into the EcoRV/XbaI site of pUC19M (Clontech, Palo Alto, CA), a derivative of pUC19 having the EcoRI site replaced by EcoRV. After mutagenesis and for microinjection into neurons and in vitro transcription/translatlon, wild-type and mutant constructs were all subcloned into the EcoRI/XbaI sites of pcDNAI/amp (Invitrogen, San Diego, CA). In this vector, the expression of the bcl-2 cDNA is driven by the cytomegelovirus promoter.
Site-directed Mutagenesis
Site-directed mutagenesis was carried out using the Transformer" sitedirected mntagenesis kit from Clontech, according to the protocol provided by the manufacturer. All the mutant bol-2 cDNAs were subeloned into the EcoRl/XbaI site (for PT3, EcoRV/XbaI) of the pcDNA I amp expression vector for in vitro tranacription/transiation and microinjection into neurons. The mutagenic primers for bel-2 mutagenesis were the following: Three bel-2 mutations were generated as follows: For T1 (truncation at nt 878 or 11e186), the bel-2/pSK + was digested with BamH1, and the resulting 576-bp fragment was directly cloned into the BamH1 site of the pcDNA I/amp expression vector. Because the cloning site was not at a stop codon, T1 obtained one additional amino acid (H) encoded by 3' residing vector sequences. T2 and T3.2 were similarly generated, but via HindH and SphI digestions, respectively. T2 (truncation at nt 797 or Vail59) obtained the additional amino acids 1HHTC_~RSSMHLEGPIL, whereas T3.1 (truncation at nt 929 or Met203) was extended by the amino acids HLEGPIL.
Construction ofL929 Stably Overexpressing bcl-2
CsCl-purified sense orientation pMV12 plasmids alone or carrying either full-length wild-type or T3.1 truncated mutant bcl-2 eDNA (10/~g) were transfected into subconfluent ~b2 cells with 25 #tg of lipofectin (GIBCO BRL, Gaithersburg, MD) to produce recombinant routine Moloney retroviruses (21) . After 48 h, the culULre medium containing viruses was collected, filtered, and stored at -70°C. 5 x 105 recipient L929 cells (subconfluent) were infected with the virus-containing medium in the presence of 8 ~g/ml of polybrene. 48 h later, the cells were trypsinized and replated into medium containing 400 ~g/ml of hygromycin B (Calbiocbem-Novabiochem Corp., La Jolla, CA). Resistant clones of L929 cells were picked by ring isolation after 2 wk of selection. Clones and mixed cell populations were expanded and analyzed for bcl-2 expression by Western blots. Two cell lines overexpressing either wild-type bcl-2 (L929bcl-2/5) or the T3.1 mutant (L929T3/3) were used for further studies. In addition, vector control lines were established (L929pMVI2/2).
TNF-~-induced Apoptosis
L929 or their derivatives expressing either wild-type or T3.1 bci-2 were seeded into 24-well plates at a concentration of 5 × 105 cells/ml. After 12 h, the cells were treated with 3 ng/ml mouse TNF-~x (Boehringer-Mannheim Biocbemicals, Indianapolis, IN). At the times indicated, half of the cells per well were trypsinized, stained with trypan blue, and counted under the microscope to determine cell viability. In parallel, the other half of the cells was collected by centrifugation and washed in 20 mM Tris-HCl (pH 8.0). DNA was phenol/chloroform extracted, treated with RNase (Boehringer-Mannheim Biochemicals) for 15 min at 37"C and electrophoresed on a 2% agarose gel to determine the degree of DNA ladder formation.
Microinjection of bcl-2 cDNAs into Neurons and Cell
Survival Assay
Neurons were cultured in 3.5-cm diameter dishes for 7 d. Rectangles (10 × 3 ram) containing 150-200 neurons were drawn on the bottom of each dish to allow localization of injected neurons. Doubly CsCl-purified circular PeDNA I amp plasmids containing various bcl-2 mutant cDNAs were dissolved in H20 at a concentration of 0.05/,g/ml. Approximately 500 DNA molecules were introduced into one cell nucleus with a low pressure microinjection system (automatic injector; Inject+Matic, Geneva) to ensure high neuronal survival (25) . 3 h after injection, the NGF-containing medium was replaced with NGF-free medium. The medium was changed daily. Survival of neurons was analyzed by morphological criteria. Neuronal death was clearly recognized by shrinkage and fragmentation of cell body and neurites (26) .
In Vitro Transcription and Translation
In vitro transcription and translation was carried out exactly as described previously (13) . eDNA fragments were cloned into the pcDNA I/amp expression vector. After linearization by NheI, the plasmids served as templates for in vitro transcription of RNA using SP6 RNA polymerase (37) (Promega Corp., Madison, W1). RNA products (0.5 ~g) were translated in vitro using a rabbit reticulocyte lysate cell-free translation system (Promega Corp.) at 30°C for 45-60 min in the presence of 1 mCi/ml [35S]methionine, as previously described (37) . Microsomal vesicles (Promega Corp.), at a concentration of 3.0 eq/0.5 mg of initial RNA in a 25-/~1 translation reaction, were included in the reticulocyte translation reaction, and samples were incubated for an additional 30 rain at 30°C. Translation was terminated by the addition of cycloheximide at a final concentration of 20/,g/ml. At this point, a membrane-stabilizing agent, tetracaine (27) , was added to a final concentration of 2 raM, followed by 5 rain of incubation at 24°C. All subsequent steps were carried out at 4°C. Sedimentation of the membrane vesicles was performed at pH 8.0 and 11.5 as described (27) by layering the reaction mixture over a 0.5-M sucrose cushion and centrifuging in an alrfuge (A100/18 rotor; Beckman Instruments, Inc., Fullerton, CA) for 5 rain at 20 p.s.i. The entire superuatant solution (including the sucrose cushion) was removed, the membrane pellet was resuspended into the same volume, and both samples were analyzed by SDS-PAGE. As a positive control for translocation into microsomes, we concomitantly in vitro transcribed/translated a ~-lactamase eDNA.
SubceUular Fractionation
Proteins were extracted as follows: Cells were washed three times in phosphate-buffered saline, and either immediately lysed in preheated (95°C) extraction buffer A (20 mM Tris-HCl, pH 7.5, 2 mM EDTA, 2 mM EGTA, 6 mM/~-mercaptoethanol, 2/tg/ml aprotinin, and 10 ~tg/ml leupeptin) containing 1% SDS followed by sonication (total extracts) or scraped into ice-cold buffer A, lysed by sonication, and centrifuged at 100,000 g for 1 h, yielding the soluble cytosol and the particulate membrane pellet (8, 9) . The particulate fraction was solubilized in preheated buffer A containing 1% SDS. The protein content in these extracts was determined according to a modified method of Bradford (10) .
lmmunoblot and Immunocytochemical Analysis
Immunoblot analysis of the cytosolic, membrane, and total extracts were perfomed exactly as described previously (8, 9) . Briefly, after SDS-POlyacrylamide gel electrophoresis on a 12 % acrylamide gel (43), proteins were electrntransferred (Bio Pad Laboratories, Richmond, CA) as described by Towbin et al. (59) . The membrane was subsequently stained with 0.2 % Ponceau red to assure equal protein loading and transfer. Membranes were then incubated for 90 rain with primary bcl-2 antibodies in a 1:2,000 dilution (for monospectic antibodies, 1:500) in blocking buffer. The immunocomplex was visualized by colorization with alkaline phosphatase-conjugated goat anti-rabbit secondary antibodies and nitro blue tetrazolium and 5-bromo-4-clfloro-3-indoylphosphate as substrates. For immunocytocbemical analysis, microinjected neurons were kept in NGF-rich medium for 3 d, and L929 fibroblasts were grown in sernm-contalning medium overnight on coverslips before bcl-2 immunoreactivity was measured. Both types of cells were fixed in 3 % paraformaldebyde, permeabflized in 0.05 % saponin in PBS, and incubated with anti-bcl-2 and then FITC-conjugated goat antirabbit IgG antibodies. Immunolocalization of bel-2 was performed by a Bio Pad confocal microscope.
Results
Generation of bcl-2 Mutants
To decipher functional domains in bcl-2, we considered the following regions as targets for mutagenesis: (a) the COOH terminus previously implicated in survival activity and membrane targeting; (b) stretches of amino acids including domain II (50) and two cysteines that are highly conserved between human, mouse, and chicken homologues of bcl-2 (18); and (c) three motifs that have been shown in other pro- DELl and DEL2 mutants exhibit structural similarities with bax and oclx-s, respectively. Survival activity was measured in neurons deprived of NGF or in L929 fibroblast exposed to TNF-o~ (between parenthesis). Localization of bel-2 was determined by confocal microscopy in neurons and in 3T3 fibroblasts (see Fig. 3 ). n.d., not determined.
teins to serve as protein-protein interaction modules. The latter include a variation of the so-called retinoblastoma gene product (Rb) binding "pocket" (LxCxE -DxxxLxDL/MxxL; in bcl-2: VxCxE -ExxxLxDNxxL) present in the adenovirus E1A, SV40 largeTAg, papillomavirus HPV ET, cyclin D, and Elf proteins (17, 65) , the sequence EYLN found in the human EGF receptor which, when phosphorylated on tyrosine, interacts with the signaling molecule Sem-5/GRB2 (55), and a putative nuclear pore degenerate sequence xFxFG present in pore proteins, such as p62, NUP1, nup153, and NSP1 (57) .
Survival Activity of bcl-2 Mutants
The survival activities of the above described bcl-2 mutants were examined by microinjecting their cDNAs into the nuclei of sympathetic neurons. We have previously shown that microinjection of the wild-type human bcl-2 cDNA markedly enhanced the lifespan of these neurons in the absence of NGF (26) . Here, we show that this is also the case for the murine bcl-2 counterpart (Figs. 1 and 2 bcl-2 fully retained viability. The survival activity of bcl-2 was maintained when the two conserved cysteines, Cys155 (PT1) or Cys226 (PT2), were mutated to histidines (Fig. 1) . Cys155 is contained within a putative Rb-binding pocket (17, 65) . According to previous findings with classical Rbbinding proteins, this mutation should have ablated survival activity, if an interaction between bcl-2 and Rb would be necessary for bcl-2 function (17, 65) . Cys226 is part of the COOH-terminal hydrophobic stretch. This residue has been implicated in the interaction of bcl-2 with membrane proteins (11) . Our data indicate that such an interaction, if it indeed occurs, has no significance for bcl-2 activity. No role for survival activity also appears to play a putative SH2 binding domain in the central part of bcl-2. This is because point mutation of tyr177 (PT3), the critical residue for a possible interaction with an SH2 domain (55), does not alter the capacity of bcl-2 to protect neurons from cell death (Fig. 1) . In contrast, deletion of a putative nuclear pore degenerate sequence (xFxFG) (DEL4) (57) did partly mitigate the survival activity of bcl-2 ( Fig. 1 ). An interesting picture was obtained when we created deletions and truncations within highly conserved regions of bcl-2. We focused our analysis on the NH~ terminus, the most conserved (up to 100%) internal part (domain 4), and the COOH terminus of bcl-2 ( Fig. 1) . Deletion of the first NH2-terminal 29 amino acids (S-N domain, DELl), as well as the removal of the internal domain 4 of bcl-2 (DEL2), fully destroyed the ability of bcl-2 to confer cell survival to NGF-deprived neurons (Fig. 1) . Because in vitro translation analysis revealed no stable protein product of the DEL2 mutant (in contrast to DELl, data not shown), we cannot exclude that the lack of activity is simply caused by translation inefficiency.
As previously described (3), removal of the last COOHterminal 50 amino acids (truncation at Ile 186, T1) fully ablates the survival activity of bcl-2 ( Fig. 1) . A further truncation at amino acid 159 (T2) had the same effect (Fig. 1) . Truncation at Asp 193 (T4) had a mitigating effect on cell survival (Fig. 1) . This mutated bcl-2 essentially resembles bcl-2~ without its unique carboxyterminal tail (Fig. 1) . When truncations were applied further carboxyterminal to T4, i.e., in the region unique to bcl-2~, survival activity of bcl-2 was at least partly retained. "15, a truncation mutant at Vail96 rescued 18 % (Fig. 2 A) , wheras T7 (truncation at Pro201), T6 (truncation at Ser202) rescued NGF-deprived neurons from cell death as efficiently as wild-type bcl-2 ( Fig.  1) . Consistent with these truncation mutants, deletion of Gin 187-Phe207 (DEL3) fully ablated survival activity of bcl-2 (Fig. 1) . The deletion mutant was in vitro translated (data not shown) into a protein of correct size.
The most intriguing mutant was T3, a truncation at Met203. This mutant was constructed by two means (see Materials and Methods): (a) by restriction digest cloning, adding seven amino acids coded by the vector seqeunee before the stop signal(T3.1), and (b) by site-directed mutagenesis, introducing a stop codon after Met203 (T3.2). As expected from the analysis of T7 and T6, T3.1 and T3. at least equally active as wild-type bcl-2 when injected into neurons ( Figs. 1 and 2 ). Taken together, our mutagenesis studies revealed that the carboxy-terminal membrane attachment domain is not required for bcl-2 activity.
To obtain further evidence that truncation mutants lacking the hydrophobic COOH-terminal tail of bcl-2 exhibit survival activity, we stably overexpressed T3.1 in L929 fibroblasts. Consistent with a previous report (31) , treatment of L929 cells with 3 ng/mi of mouse TNF-ct triggers apoptosis (Fig. 2) . Based on trypan blue exclusion staining, we found that only 18 % of the cells survived such treatment for 24 h. Overexpression of the wild-type murine bcl-2, however, extended survival to 60% (Fig. 2) . As in the neuronal assay, the T3.1 mutant was as active as wild-type bcl-2. Its overexpression protected up to 75 % of the fibroblasts from TNFinduced cell death after 24 h of treatment (Fig. 2 C) . This was seen with three independent cell clones expressing high levels of the construct as well as in a mixed cell population of overexpressers (data not shown). Overexpression of wildtype bcl-2 and the T3.1 mutant also led to a drastic delay of TNF-mediated DNA fragmentation in these cells (data not shown).
Bax was shown to regulate the activity of bcl-2 in a dominant negative fashion, most likely by forming heterodimers (50) . Although bax and bcl-2 display a high overall sequence similarity, bax is lacking 25 residues close to the NH2 terminus. Because our DELl mutant resembled the structure of bax with respect to this deletion (Fig. 1 , DELl, residues 4-29; BAY, residues 7-31 ), we tested whether the absence of the corresponding amino acids could explain the inhibitory activity of Bax on bcl-2. Bcl-2 remained, however, equally active when coinjected into neurons with an excess of DELl mutant, indicating that additional structural features are required for heterodimerization (data not shown). Negative results were also obtained when the bcl-x,-like mutant DEL2 was assayed for its inhibitory activity on bcl-2 (data not shown).
Association of bcl-2 Mutants with Subcellular Structures In Viw
Since the hydrophobic 26 amino acids at the carboxy terminus were found to constitute a transmembrane domain that anchors bcl-2 in the intracellular membranes (11), it was important to investigate whether its absence in the active truncation mutants was associated with an altered subcellular For immunocytochemical studies, we injected the various mutant cDNAs into sympathetic neurons or analyzed L929 fibroblasts stably overexpressing the mutants. We recognized the previously reported (35) , punctuated staining characteristic of mitochondria in cells injected with wild-type bcl-2 (Fig. 3 A) . This was best observed in L929 cells where the nuclear background staining was weak (Fig. 3 B) . By contrast, the T3.1 mutant bel-2 associated with cellular structures not previously seen with wild-type bcl-2 immunofluorescence: neurite extensions in neurons (Fig. 3 A) and filopodias in fibroblasts (Fig. 3 B) . This is consistent with a release of T3.1 from intracetlular membrane structures and a departure to cellular extremities.
Consistent with this notion, Western blot analyses of cytosolic and membrane extracts from L929 cells stably overexpressing either wild-type or T3.1 bel-2 demonstrated that while the 26-kD wild-type bcl-2 mainly associated with the particulate fraction, the 24-kD T3.1 is predominantly soluble (Fig. 4) . It should be noted, however, that association with the respective compartment is not absolute. Approximately 10-20% of wild-type bcl-2 appears to be soluble under normal growth conditions (Fig. 4) . A small portion of T3 also remains membrane attached (Fig. 4) .
Membrane Association of bci-2 Mutants In Vitro
The removal of the carboxyl terminal hydrophobic stretch has been shown to create a form of bel-2 that is incapable of inserting into microsomes after in vitro translation (13) . Wild-type and mutant bcl-2 cDNAs used for microinjection into neurons (cloned into PeDNA I amp) were, therefore, subjected to T7 polymerase-directed in vitro transcription/translation in the presence and absence of microsomes (cotranslational insertion) (Fig. 5) . In this method, ~-lactamase, a signal peptide-containing protein normally translocates into the microsomes (Fig. 5) . Surprisingly, in contrast to a previous report (13) , wild-type bcl-2 did not partition completely into the microsomal fraction. At least 30% of the in vitro-translated wild-type protein and even 50 % of the TI,'I2 mutants were recovered in the supernatant (Fig. 5) . In contrast, the T3.1 mutant was fully recovered in the supernatant (Fig. 5) .
Discussion
Domain 4 of bcl-2 contains two highly conserved segments (S-I and S-H) and three regions with similarity to known functional motifs, i.e. an Rb-binding pocket, an SH2 binding domain and a nuclear pore degenerate motif. Our mutagenesis studies speak against an involvement of the Rb-and SH2-binding motifs in the survival activity of bcl-2. In contrast, the excision of the putative nuclear pore sequence led to a partial loss of activity (',,20 %). This raises the possibility of a role for bcl-2 in some aspect of nuclear transport, nuclear pore complex formation, or nuclear envelope assembly or maintenance. Consistent with this notion is the recent immunolocalization of bcl-2 to patches of the nuclear envelope that are highly reminiscent of nuclear pore complexes (42) . We can, however, not exclude that the removal of the putative nuclear pore sequence simply distorts the structure of the adjacent extremely conserved S-I segment, which is thought to be of functional importance (50) .
The NH2-terminal region (S-N) is highly conserved between the bel-2 of different species and bcl-x, suggesting a role in protein-protein interaction. Indeed, the deletion of 26 amino acids (residues 4-29) at the NH2 terminus corn- Figure 5 . In vitro synthesis of wild-type and mutant bel-2. In vitro synthesis of bcl-2 and its truncated mutants, T1, 1"2, and T3. cDNAs were transcribed, and the resulting RNAs were translated in vitro using rabbit reticulocyte lysate containing
[35S]methionine in the presence of microsomai vesicles. Membrane associated protein (p) was separated from soluble proteins(s) by high speed centrifugation at pH 11.5. Samples were analyzed by SDS-PAGE and by fluorograpby. The two left lanes are controls with/3-1actamase, which translocates into the lumen of microsomes thereby liberating its signal peptide (reduction of molecular mass). At pH 11.5, microsomes lose their luminai content, and ~-lactamase is recovered in the soluble, nonmembranous fraction. pletely impaired the survival activity of bcl-2. Because the translation of this mutant was efficient in vitro, a crucial role of the NH2-terminal residues for the survival activity is likely. Interestingly, bax, which induces rather than prevents cell death, lacks this particular S-N domain.
Survival activity
Our results provide clear evidence that a stretch of amino acids within domain 4 (S-II) and its COOH-terminal extension delineated by Asp186-Vail 96 at the beginning of domain 5 (S-H-C) is crucial for its function (Fig. 5) . The S-II region is highly conserved not only among different bcl-2 homologues (bax, bcl-x, and bcl-2/3) (7, 50, 60) but also among other putative cell survival factors. These include MCL1 (40), a gene product involved in programmed myeloid cell differentiation, A1 (45), a hemopoietic-specific early response gene, and BHRF1 (15) and LMW5-HL (47) , two viral genes involved in the survival of host cells during productive and/or persistent infections of Epstein-Barr virus and African swine fever viruses, respectively. The S-II region (Trp185-Trp192) is especially intriguing because it is located just before the site where bcl-2ot and bcl-2/~ are differentially spliced (Fig. 6) . Given the finding that our mutant T4 (ends at Asp193) is inactive in conferring cell survival, it is likely that this amino acid stretch alone is not sufficient for survival activity. It becomes fully active only when joined to at least five to nine additional residues. This extension probably assures the structural and functional integrity of the S-II segment. Indeed, the mutant T7 (additional nine residues, Asp193-Pro201) was as functional as the wildtype, whereas the addition of only 4 amino acids (mutant T5, 193-196) led to only partial recovery. Considering that the S-II-C segments of the highly active BHRF1 protein (Fig. 5 ) and bcl-2 display only little sequence similarity, no or little sequence requirements seem to exist for this segment.
In view of the recent identification of bcl-2 homologues that regulate the extent ofbcl-2,~ activity through hetero-and homodimer formation (50) , it is conceivable to propose that the herein defined functional S-II/S-II-C domain could mediate dimerization. This region is well situated to generate splice variants that would still dimerize but exhibit different activities. Varied dimerization between different partners is a common mechanism for regulating cellular functions (e.g., transcriptional activity; reference 6). Such a mechanism would also provide a satisfactory explanation for the dominant negative action of bax (50) on the survival activity of bcl-2. In this respect, bax would form an inert heteromeric complex with bcl-2 similar to transcription factors that lack a DNA-binding or transactivation domain ("squelching"). Interestingly, bax has retained the S-II domain but exhibits a distinct putative S-II-C domain (50) (Fig. 6) . In contrast to bax, bcl-x, has retained the putative effector domain S-H-C, but lost the entire domain S-H (7) (Fig. 6) .
Previously, it was believed that the removal of membrane attachment site of bcl-2 leads to at least a partial impairment of its function (3), but here, we show that the membrane interaction is not obligatory. T3, a truncated form of bcl-2 lacking the COOH-terminal hydrophobic tail (amino acids 204-236) is soluble in intact cells and after in vitro synthesis, and yet is fully active in sparing neurons and fibroblasts from apoptosis. A major concern with this result could be that the T3 mutant is only marginally active but expressed at a much higher level than wild-type bel-2. According to our immunocytochemical (Fig. 3 B) and immunoblot (Fig. 4) studies, this appears, however, not to be the case because the T3 mutant was actually less expressed than its wild-type counterpart.
The survival activity of the soluble T3 mutant is not necessarily in conflict with previously published structure-function analyses, but rather, it extends the results published to date: First, a bcl-2 mutant lacking the last COOH-terminal 50 amino acids (our TI) failed to block apoptosis in baculovirus-infected St x ) insect cells (3) . In view of our data, this is presumably caused by the lack of the two putative functional domain S-II (Fig. 6 ) rather than to the absence of the COOH-terminal transmembrane stretch. Second, deletion of the last 26 amino acids including the transmembrane domain led to a failure of bcl-2 to be inserted into microsomes after in vitro transcription/translation (13) . However, the impact of this mutation on survival activity was not reported. This bcl-2 mutant was less truncated (by seven amino acids) than the herein-described T3 construct. Third, a recent study demonstrated that bcl-2/~, which has a minimal, nonconserved S-II-C domain but lacks the COOHterminal hydrophobic stretch, is inactive in sparing 32D cells from apoptosis induced by IL-3 removal (58) . Surprisingly, the addition of a heterologous transmembrane stretch of the IL-2 receptors renders bcl-2/~ at least partially active. It is possible that the activity of the S-II segment may be unveiled through cooperation with additional residues derived from the IL-2 receptor transmembrane domain (Fig. 6) . The observed partial regain of activity of the bcl-2-TM-IL-2 receptor chimeric protein would, therefore, be caused by a gain of function of the S-II domain rather than result from the membrane association. In agreement with this hypothesis are the negative results obtained with our DEL3 mutant, which still has the transmembrane domain but lacks the S-II/S-II-C domain. Fourth, Oltvai et al. (50) recently discussed in their study that a bcl-2 mutant lacking the COOHterminal 22 amino acids is cytoplasmic and partially protects cells from death. This mutant is even larger than T3 (by 11 amino acids), indicating that removal of only the transmembrahe stretch already renders bcl-2 soluble. Interestingly, the authors mention that their mutant still associates with bax (50), further strengthening the notion that dimerization motifs must lie upstream of the transmembrane region. This finding further suggests that membrane attachment may not be required for the interaction of bcl-2 with other bcl-2 homologues.
Recent results (34, 39) indicate a role for bcl-2 in an antioxidant pathway to prevent cellular damage including lipid peroxidation. The protein acts either before or after the generation of 02"-and its conversion to peroxides. It was proposed that bcl-2 could act as a trap for oxygen radicals similar to glutathione. Glutathione contains a cysteine residue that acts as a hydrogen/electron donor in the reduction of oxygen radicals. Our mutagenesis studies speak against a possible analogous involvement of Cys155 or Cys226 in the trapping of oxygen radicals by bcl-2. A third cysteine (Cys89) that was not mutated here is not conserved between human, chicken, and mouse bcl-2 (11, 18) .
O2.-radical production in vivo is localized to distinct organelles including mitochondria, ER, and nuclear membranes. Consistent with this presumptive function is the close association of bcl-2 with mitochondrial (35) or perinuclear membranes (3, 12, 38) . Our study provides evidence that bcl-2 may also fullfill its function in the cytoplasm. The soluble active T3.1 mutant migrates to neurites in neurons and filopodias in fibroblasts (Fig. 3) . These structures are known to be especially vulnerable to apoptosis and to H:O: exposure: neurites rapidly retract (33) and fibroblasts detach from their substrate. Because of its presence in cellular extensions, the T3.1 mutant may therefore efficiently protect these structures from degradation.
In summary, our data presented here demonstrate that bcl-2 can also exert its survival activity in the cytoplasm. In addition, they point towards putative functional motifs S-N and S-H/S-H-C, which lie in highly conserved domains. This finding sets the stage to more precisely define the functional domains of bcl-2, and to investigate their role in binding other bcl-2 homologues, other regulators, and effectors crucial for cell survival.
